Click HERE to download the PDF

SK pharmteco has added a new family member.  The most recent addition is YposKesi, a large molecule CDMO based in Paris, France, providing access to a modern 5000 m² facility, capable of developing and producing Adeno Associated Viral and Lentiviral Vectors for gene and cell therapy.  With the addition of YposKesi we have 7 facilities with almost 1000 m³ of small molecule reactor capacity, four independent manufacturing suites for large molecule bulk drug substance production and two fill and finish suites for drug products. Our facilities and laboratories are state-of-the-art, with a highly differentiated technology toolbox delivered by our talented workforce of ~1500 employees.